| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8669497 | The Journal of Heart and Lung Transplantation | 2018 | 26 Pages |
Abstract
Immunomodulatory therapy for CLAD with ECP or AL was associated with a significant change in FEV1 slope post-treatment compared with pre-treatment slope, with minimal effect on FVC. There was no difference between the 2 therapies in their effect on pulmonary function.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anna MD, Keri PharmD, Alexander MD, Obadah MD, Jessica MD, Patrick MD, PhD, Phillip MD, Miguel MD, Souheil MD, MPH, Hari MD, Ivan MD, Anne MD, MSc, Sophia MD, MPH, Hilary J. MD, MPH,